Summary
The effect of three new fluoroquinolones on theophylline kinetics and the urinary excretion of metabolites was studied in 5 healthy subjects (3 male, 2 female).
All subjects received serial, single i.v. infusions of theophylline (aminophylline, 250 mg) over 60 min after 200 mg doses of a quinolone (enoxacin, ofloxacin, norfloxacin) every 8 h for 3 consecutive days, the quinolone being administered up to the day following theophylline administration.
Pretreatment with ofloxacin and norfloxacin did not influence theophylline disposition, but theophylline clearance fell from 0.054 to 0.027 l·h−1·kg−1 in the presence of enoxacin, without a change in the apparent volume of distribution. Enoxacin, too, was the sole compound to increase the urinary excretion of theophylline (33.2 vs 43.9 mg, before vs after treatment), and significantly to decrease the excretion of 3-methylxanthine (3-MX), 1-methyluric acid (1-MU) and 1,3-dimethyluric acid (1,3-DMU) in 24-h urine samples (from 19.8 to 7.16 mg, from 28.3 to 10.3 mg and from 68.8 to 49.5 mg, respectively). The effect of the quinolones on hepatic drug metabolizing enzyme activity was investigated in each subject using the ratios of 6-hydroxycortisol to total 17-hydroxycorticosteroids and to free cortisol in 24-h urines as an index of the hepatic P-450-dependent enzyme system. No significant difference in ratio was observed between control and other treatments. It is concluded that the theophylline-enoxacin interaction was largely due to inhibition of a metabolic system other than the common hepatic P-450 system.
Similar content being viewed by others
References
Maesen FPV, Teengs JP, Baur C, Davies BI (1984) Quinolones and raised plasma concentration of theophylline. Lancet 2: 530
Wijnands WJA, Vree TB, Van Herwaarden CLA (1985) Enoxacin decreases the clearance of theophylline in man. Br J Clin Pharmacol 20: 583–588
Fourtillan JB, Granier J, Saint-Salvi B, Salmon J, Surjus A, Tremblay D, Vincent DU, Laurier M, Beck S (1986) Pharmacokinetics of ofloxacin and theophylline alone and in combination. Infection 14 [Suppl 1]: 67–69
Sano M, Yamamoto I, Ueda J, Yoshikawa E, Yamashina H, Goto M (1987) Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration. Eur J Clin Pharmacol 32: 431–432
Tang-Liu D D-S, Riegelman S (1982) An automated HPLC assay for simultaneous quantitation of methylated xanthines and uric acids in urine. J Chromatogr Sci 20: 155–159
Yamada S, Iwai K (1976) Induction of hepatic cortisol-6-hydroxylase by rifampicin. Lancet 2: 366–367
Silver RH, Porter CC (1954) The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem 210: 923–932
Reddy WJ, Jenkins D, Thorn GW (1952) Estimation of 17-hydroxycorticoids in urine. Metabolism 1: 511–527
Yamaoka K, Tanigawara Y, Nakagawa T, Uno T (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobiodyn 4: 879–885
Gibaldi M, Perrier D (1975) One-compartment model. In: Pharmacokinetics. Marcel Dekker, New York, pp 1–43
Bolton S (1984) Analysis of variance. In: Pharmaceutical statistics. Marcel Dekker, New York, pp 218–256
Grygiel JJ, Miners JO, Drew R, Birkett DJ (1984) Differential effects of cimetidine on theophylline metabolic pathways. Eur J Clin Pharmacol 26: 335–340
Grygiel JJ, Birkett DJ, Phil D (1980) Effect of age on patterns of theophylline metabolism. Clin Pharmacol Ther 28: 456–462
Ogilvie RI (1978) Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 3: 267–293
Bukowsky JM, Nakatsu K, Munt PW (1984) Theophylline reassessed. Ann Intern Med 101: 63–73
Ohnhaus EE, Park BK (1979) Measurement of urinary 6-β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol 15: 139–145
Park BK, Breckenridge AM (1981) Clinical implication of enzyme induction and enzyme inhibition. Clin Pharmacokinet 6: 1–24
Morita K, Konishi H, Ono T, Shimakawa H (1987) A comparison of the inhibitory effects of roxatidine acetate hydrochloride and cimetidine on cytochrome P-450-mediated drug metabolism in mouse hepatic microsomes and in man in vivo. J Pharmacobiodyn 10: 287–295
Hunt SN, Jusko WJ, Yurchak AM (1976) Effect of smoking on theophylline disposition. Clin Pharmacol Ther 19: 546–551
Jenne JW, Nagasawa H, McHugh R, McDonald F, Wyse E (1975) Decreased theophylline half-life in cigarette smokers. Life Sci 17: 195–198
Landay RA, Gonzalez MA, Taylor JC (1978) Effect of phenobarbital on theophylline disposition. J Allergy Clin Immunol 62: 27–29
Challiner M, Park BK, Odum J, Orton TC (1981) The effect of 3-methylcolanthrene on urinary 6-β-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey. Biochem Pharmacol 30: 2131–2134
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sano, M., Kawakatsu, K., Ohkita, C. et al. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans. Eur J Clin Pharmacol 35, 161–165 (1988). https://doi.org/10.1007/BF00609246
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609246